Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-04-23 @ 6:14 AM
Study NCT ID:
NCT03355157
Status:
COMPLETED
Last Update Posted:
2024-10-01
First Post:
2017-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
Sponsor:
GBG Forschungs GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-22
First Submit QC Date:
None
Study First Post Date:
2017-11-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-10-01
Last Update Post Date Type:
ACTUAL